batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Lynparza set for an unexpected EU approval 1 July 2024 Astra reveals more about its TIGIT hand 27 June 2024 End of the road for Imfinzi in adjuvant lung? 25 June 2024 Dethroning Opdivo in bladder cancer falls to Niagara 25 June 2024 ISTH 2024 – Takeda's marker for Genmab and Sanofi 24 June 2024 Syncona goes deeper into oncology 20 June 2024 iTeos’s TIGIT goes pivotal at last 19 June 2024 Day One goes where Pfizer and AbbVie feared to tread 19 June 2024 Load More